{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:07:30Z","timestamp":1778674050141,"version":"3.51.4"},"reference-count":172,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K23AR085191"],"award-info":[{"award-number":["K23AR085191"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s40257-026-01010-9","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T16:03:17Z","timestamp":1775750597000},"page":"587-609","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Acute and Chronic Cutaneous Graft-versus-Host Disease: Diagnosis, Treatment, and Emerging Directions"],"prefix":"10.1007","volume":"27","author":[{"given":"Connie R.","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihir K.","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grant J.","family":"Riew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Badri","family":"Modi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina","family":"Markova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward W.","family":"Cowen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Baumrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"issue":"22","key":"1010_CR1","doi-asserted-by":"publisher","first-page":"5829","DOI":"10.1182\/bloodadvances.2024012722","volume":"8","author":"PA Carpenter","year":"2024","unstructured":"Carpenter PA, Gooley TA, Boiko J, Lee CJ, Burroughs LM, Mehta R, et\u00a0al. Decreasing chronic graft-versus-host disease rates in all populations. Blood Adv. 2024;8(22):5829\u201337.","journal-title":"Blood Adv."},{"issue":"25","key":"1010_CR2","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1056\/NEJMoa2215943","volume":"388","author":"J Bola\u00f1os-Meade","year":"2023","unstructured":"Bola\u00f1os-Meade J, Hamadani M, Wu J, Malki MMA, Martens MJ, Runaas L, et\u00a0al. Post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis. N Engl J Med. 2023;388(25):2338\u201348.","journal-title":"N Engl J Med."},{"issue":"2","key":"1010_CR3","first-page":"107","volume":"31","author":"GL Molaro","year":"1984","unstructured":"Molaro GL, De Angelis V. Graft versus host disease after transfusion of blood and its products. Riv Emoter Immunoematol. 1984;31(2):107\u201323.","journal-title":"Riv Emoter Immunoematol."},{"issue":"12","key":"1010_CR4","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1097\/TP.0000000000001406","volume":"100","author":"AR Murali","year":"2016","unstructured":"Murali AR, Chandra S, Stewart Z, Blazar BR, Farooq U, Ince MN, et\u00a0al. Graft versus host disease after liver transplantation in adults: a case series, review of literature, and an approach to management. Transplantation. 2016;100(12):2661.","journal-title":"Transplantation."},{"issue":"2","key":"1010_CR5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/ajh.22227","volume":"87","author":"C Fidler","year":"2012","unstructured":"Fidler C, Klumpp T, Mangan K, Martin M, Sharma M, Emmons R, et\u00a0al. Spontaneous graft versus host disease occurring in a patient with multiple myeloma after autologous stem cell transplant. Am J Hematol. 2012;87(2):219\u201321.","journal-title":"Am J Hematol."},{"issue":"1","key":"1010_CR6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1182\/blood-2016-07-686642","volume":"129","author":"SJ Lee","year":"2017","unstructured":"Lee SJ. Classification systems for chronic graft-versus-host disease. Blood. 2017;129(1):30\u20137.","journal-title":"Blood."},{"issue":"4","key":"1010_CR7","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1182\/blood-2014-08-551994","volume":"125","author":"MED Flowers","year":"2015","unstructured":"Flowers MED, Martin PJ. How we treat chronic graft-versus-host disease. Blood. 2015;125(4):606\u201315.","journal-title":"Blood."},{"issue":"3","key":"1010_CR8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","volume":"21","author":"MH Jagasia","year":"2015","unstructured":"Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, et\u00a0al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant. 2015Mar 1;21(3):389\u2013401 (e1).","journal-title":"Biol Blood Marrow Transplant."},{"issue":"9","key":"1010_CR9","doi-asserted-by":"publisher","first-page":"S513","DOI":"10.1016\/j.jtct.2024.05.020","volume":"30","author":"CR Shi","year":"2024","unstructured":"Shi CR, Ferreira AL, Kaur M, Xiang D, Caputo J, Choe HK, et\u00a0al. Cutaneous chronic graft-versus-host disease: clinical manifestations, diagnosis, management, and supportive care. Transplant Cell Ther. 2024;30(9):S513-33.","journal-title":"Transplant Cell Ther."},{"issue":"1","key":"1010_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2022.12.024","volume":"90","author":"E Baumrin","year":"2024","unstructured":"Baumrin E, Loren AW, Falk SJ, Mays JW, Cowen EW. Chronic graft-versus-host disease. Part I: epidemiology, pathogenesis, and clinical manifestations. J Am Acad Dermatol. 2024;90(1):1\u201316.","journal-title":"J Am Acad Dermatol."},{"issue":"12","key":"1010_CR11","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","volume":"11","author":"AH Filipovich","year":"2005","unstructured":"Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et\u00a0al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant. 2005;11(12):945\u201356.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"1010_CR12","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/s41375-020-0804-2","volume":"34","author":"F Malard","year":"2020","unstructured":"Malard F, Huang XJ, Sim JPY. Treatment and unmet needs in steroid-refractory acute graft-versus-host disease. Leukemia. 2020;34(5):1229\u201340.","journal-title":"Leukemia."},{"issue":"22","key":"1010_CR13","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1056\/NEJMra1609337","volume":"377","author":"R Zeiser","year":"2017","unstructured":"Zeiser R, Blazar BR. Acute graft-versus-host disease - Biologic process, prevention, and therapy. N Engl J Med. 2017;377(22):2167\u201379.","journal-title":"N Engl J Med."},{"issue":"1","key":"1010_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-023-00438-1","volume":"9","author":"F Malard","year":"2023","unstructured":"Malard F, Holler E, Sandmaier BM, Huang H, Mohty M. Acute graft-versus-host disease. Nat Rev Dis Primer. 2023;9(1):1\u201318.","journal-title":"Nat Rev Dis Primer."},{"issue":"11","key":"1010_CR15","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1182\/blood-2010-08-302109","volume":"117","author":"MED Flowers","year":"2011","unstructured":"Flowers MED, Inamoto Y, Carpenter PA, Lee SJ, Kiem HP, Petersdorf EW, et\u00a0al. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria. Blood. 2011;117(11):3214\u20139.","journal-title":"Blood."},{"issue":"6","key":"1010_CR16","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1046\/j.1365-2133.2003.05336.x","volume":"148","author":"E Vargas-D\u00edez","year":"2003","unstructured":"Vargas-D\u00edez E, Fern\u00e1ndez-Herrera J, Marin A, C\u00e1mara R, Garc\u00eda-D\u00edez A. Analysis of risk factors for acute cutaneous graft-versus-host disease after allogeneic stem cell transplantation. Br J Dermatol. 2003;148(6):1129\u201334.","journal-title":"Br J Dermatol."},{"issue":"17","key":"1010_CR17","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1182\/blood.2023023660","volume":"144","author":"LS Kean","year":"2024","unstructured":"Kean LS, Burns LJ, Kou TD, Kapikian R, Lozenski K, Langston A, et\u00a0al. Abatacept for acute graft-versus-host disease prophylaxis after unrelated donor hematopoietic cell transplantation. Blood. 2024;144(17):1834\u201345.","journal-title":"Blood."},{"issue":"11","key":"1010_CR18","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.bbmt.2014.06.031","volume":"20","author":"D Ion","year":"2014","unstructured":"Ion D, Stevenson K, Woo SB, Ho VT, Soiffer R, Antin JH, et\u00a0al. Characterization of oral involvement in acute graft-versus-host disease. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2014;20(11):1717\u201321.","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant."},{"issue":"12","key":"1010_CR19","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1016\/j.bbmt.2015.08.030","volume":"21","author":"RF Cornell","year":"2015","unstructured":"Cornell RF, Hari P, Drobyski WR. Engraftment syndrome after autologous stem cell transplantation: an update unifying the definition and management approach. Biol Blood Marrow Transplant. 2015;21(12):2061\u20138.","journal-title":"Biol Blood Marrow Transplant."},{"issue":"4","key":"1010_CR20","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.jaad.2010.07.042","volume":"65","author":"HJ Byun","year":"2011","unstructured":"Byun HJ, Yang JI, Kim BK, Cho KH. Clinical differentiation of acute cutaneous graft-versus-host disease from drug hypersensitivity reactions. J Am Acad Dermatol. 2011;65(4):726\u201332.","journal-title":"J Am Acad Dermatol."},{"issue":"4","key":"1010_CR21","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jaad.2004.02.019","volume":"51","author":"DE Marra","year":"2004","unstructured":"Marra DE, McKee PH, Nghiem P. Tissue eosinophils and the perils of using skin biopsy specimens to distinguish between drug hypersensitivity and cutaneous graft-versus-host disease. J Am Acad Dermatol. 2004;51(4):543\u20136.","journal-title":"J Am Acad Dermatol."},{"issue":"2","key":"1010_CR22","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1001\/archderm.142.2.175","volume":"142","author":"BF Firoz","year":"2006","unstructured":"Firoz BF, Lee SJ, Nghiem P, Qureshi AA. Role of skin biopsy to confirm suspected acute graft-vs-host disease: results of decision analysis. Arch Dermatol. 2006;142(2):175\u201382.","journal-title":"Arch Dermatol."},{"issue":"6","key":"1010_CR23","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1001\/archderm.136.6.717","volume":"136","author":"Y Zhou","year":"2000","unstructured":"Zhou Y, Barnett MJ, Rivers JK. Clinical significance of skin biopsies in the diagnosis and management of graft-vs-host disease in early postallogeneic bone marrow transplantation. Arch Dermatol. 2000;136(6):717\u201321.","journal-title":"Arch Dermatol."},{"issue":"5","key":"1010_CR24","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1111\/jdv.12737","volume":"29","author":"U Hillen","year":"2015","unstructured":"Hillen U, H\u00e4usermann P, Massi D, Janin A, Wolff D, Lawitschka A, et\u00a0al. Consensus on performing skin biopsies, laboratory workup, evaluation of tissue samples and reporting of the results in patients with suspected cutaneous graft-versus-host disease. J Eur Acad Dermatol Venereol JEADV. 2015;29(5):948\u201354.","journal-title":"J Eur Acad Dermatol Venereol JEADV."},{"issue":"1","key":"1010_CR25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","volume":"22","author":"AC Harris","year":"2016","unstructured":"Harris AC, Young R, Devine S, Hogan WJ, Ayuk F, Bunworasate U, et\u00a0al. International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium. Biol Blood Marrow Transplant. 2016;22(1):4\u201310.","journal-title":"Biol Blood Marrow Transplant."},{"issue":"S3","key":"1010_CR26","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/ajh.27593","volume":"100","author":"AK Mehta","year":"2025","unstructured":"Mehta AK, Koreth J. Toward improving initial therapy of acute graft versus host disease. Am J Hematol. 2025;100(S3):40\u201354.","journal-title":"Am J Hematol."},{"issue":"6","key":"1010_CR27","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et\u00a0al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant. 1995;15(6):825\u20138.","journal-title":"Bone Marrow Transplant."},{"issue":"11","key":"1010_CR28","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/s41409-018-0204-7","volume":"53","author":"HM Schoemans","year":"2018","unstructured":"Schoemans HM, Lee SJ, Ferrara JL, Wolff D, Levine JE, Schultz KR, et\u00a0al. EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment. Bone Marrow Transplant. 2018;53(11):1401\u201315.","journal-title":"Bone Marrow Transplant."},{"issue":"6","key":"1010_CR29","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/j.1365-2141.2012.09114.x","volume":"157","author":"ML MacMillan","year":"2012","unstructured":"MacMillan ML, DeFor TE, Weisdorf DJ. What predicts high risk acute graft-versus-host disease (GVHD) at onset?: Identification of those at highest risk by a novel acute GVHD risk score. Br J Haematol. 2012;157(6):732\u201341.","journal-title":"Br J Haematol."},{"issue":"9","key":"1010_CR30","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1182\/blood.2024025106","volume":"144","author":"Y Akahoshi","year":"2024","unstructured":"Akahoshi Y, Spyrou N, Weber D, Aguayo-Hiraldo P, Ayuk F, Chanswangphuwana C, et\u00a0al. Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD. Blood. 2024;144(9):1010\u201321.","journal-title":"Blood."},{"issue":"5","key":"1010_CR31","doi-asserted-by":"publisher","first-page":"599","DOI":"10.6004\/jnccn.2020.0021","volume":"18","author":"A Saad","year":"2020","unstructured":"Saad A, de Lima M, Anand S, Bhatt VR, Bookout R, Chen G, et\u00a0al. Hematopoietic cell transplantation, version 2.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2020;18(5):599\u2013634.","journal-title":"J Natl Compr Canc Netw"},{"issue":"9","key":"1010_CR32","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.bbmt.2016.04.022","volume":"22","author":"AM Ali","year":"2016","unstructured":"Ali AM, DiPersio JF, Schroeder MA. The role of biomarkers in the diagnosis and risk stratification of acute graft vs. host disease (aGvHD): a systematic review. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2016;22(9):1552\u201364.","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant."},{"issue":"10","key":"1010_CR33","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.jtct.2022.07.008","volume":"28","author":"A Bidgoli","year":"2022","unstructured":"Bidgoli A, DePriest BP, Saatloo MV, Jiang H, Fu D, Paczesny S. Current definitions and clinical implications of biomarkers in graft-versus-host disease. Transplant Cell Ther. 2022;28(10):657\u201366.","journal-title":"Transplant Cell Ther."},{"issue":"Suppl 3","key":"1010_CR34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/ajh.27594","volume":"100","author":"JE Levine","year":"2025","unstructured":"Levine JE. Prediction and prognostication of acute graft-versus-host disease by MAGIC biomarkers. Am J Hematol. 2025;100(Suppl 3):5\u201313.","journal-title":"Am J Hematol."},{"issue":"6","key":"1010_CR35","doi-asserted-by":"publisher","first-page":"603.e1","DOI":"10.1016\/j.jtct.2024.03.022","volume":"30","author":"M Qayed","year":"2024","unstructured":"Qayed M, Kapoor U, Gillespie S, Westbrook A, Aguayo-Hiraldo P, Ayuk FA, et\u00a0al. A validated risk stratification that incorporates MAGIC biomarkers predicts long-term outcomes in pediatric patients with acute GVHD. Transplant Cell Ther. 2024;30(6):603.e1-603.e11.","journal-title":"Transplant Cell Ther."},{"issue":"6","key":"1010_CR36","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/MOH.0000000000000681","volume":"28","author":"S Kaviany","year":"2021","unstructured":"Kaviany S, Kitko CL. The role of biomarkers in risk stratification, treatment and outcome in acute GVHD. Curr Opin Hematol. 2021;28(6):401\u20137.","journal-title":"Curr Opin Hematol."},{"issue":"2","key":"1010_CR37","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3324\/haematol.2019.220970","volume":"105","author":"ML MacMillan","year":"2020","unstructured":"MacMillan ML, DeFor TE, Holtan SG, Rashidi A, Blazar BR, Weisdorf DJ. Validation of Minnesota acute graft-versus-host disease Risk Score. Haematologica. 2020;105(2):519\u201324.","journal-title":"Haematologica."},{"issue":"4","key":"1010_CR38","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.bbmt.2015.01.001","volume":"21","author":"ML MacMillan","year":"2015","unstructured":"MacMillan ML, Robin M, Harris AC, DeFor TE, Martin PJ, Alousi A, et\u00a0al. A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2015;21(4):761\u20137.","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant."},{"issue":"6","key":"1010_CR39","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1002\/phar.1418","volume":"34","author":"KA Olson","year":"2014","unstructured":"Olson KA, West K, McCarthy PL. Toxic tacrolimus levels after application of topical tacrolimus and use of occlusive dressings in two bone marrow transplant recipients with cutaneous graft-versus-host disease. Pharmacotherapy. 2014;34(6):e60-64.","journal-title":"Pharmacotherapy."},{"issue":"1","key":"1010_CR40","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/sj.bmt.1705234","volume":"38","author":"DL Neuman","year":"2006","unstructured":"Neuman DL, Farrar JE, Moresi JM, Vogelsang GB, Higman MA. Erratum: toxic absorption of pimecrolimus in a patient with severe acute graft-versus-host disease. Bone Marrow Transplant. 2006;38(1):81\u201381.","journal-title":"Bone Marrow Transplant."},{"issue":"3","key":"1010_CR41","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41409-023-02181-3","volume":"59","author":"Z Hudda","year":"2024","unstructured":"Hudda Z, Flannery A, Teusink-Cross A, Davies SM, Khandelwal P. Topical ruxolitinib is promising as sole or adjunctive therapy in treating maculopapular rash of acute and chronic skin GVHD. Bone Marrow Transplant. 2024;59(3):425\u20137.","journal-title":"Bone Marrow Transplant."},{"issue":"5","key":"1010_CR42","doi-asserted-by":"publisher","DOI":"10.1111\/phpp.12997","volume":"40","author":"T Fachler-Sharp","year":"2024","unstructured":"Fachler-Sharp T, Kobal I, Sheffer-Levi S, Cohen A, Hassidim A, Molho-Pessach V, et\u00a0al. Phototherapy for the treatment of cutaneous graft-versus-host disease: a systematic review. Photodermatol Photoimmunol Photomed. 2024;40(5):e12997.","journal-title":"Photodermatol Photoimmunol Photomed."},{"issue":"2","key":"1010_CR43","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/j.1365-2133.2009.09503.x","volume":"162","author":"V Brazzelli","year":"2010","unstructured":"Brazzelli V, Grasso V, Muzio F, Moggio E, Zecca M, Locatelli F, et\u00a0al. Narrowband ultraviolet B phototherapy in the treatment of cutaneous graft-versus-host disease in oncohaematological paediatric patients. Br J Dermatol. 2010;162(2):404\u20139.","journal-title":"Br J Dermatol."},{"issue":"12","key":"1010_CR44","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1038\/bmt.2010.230","volume":"45","author":"M Schlaak","year":"2010","unstructured":"Schlaak M, Schwind S, Wetzig T, Maschke J, Treudler R, Basara N, et\u00a0al. UVA (UVA-1) therapy for the treatment of acute GVHD of the skin. Bone Marrow Transplant. 2010;45(12):1741\u20138.","journal-title":"Bone Marrow Transplant."},{"issue":"5","key":"1010_CR45","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/sj.bmt.1704804","volume":"35","author":"T Wetzig","year":"2005","unstructured":"Wetzig T, Sticherling M, Simon JC, Hegenbart U, Niederwieser D, Al-Ali HK. Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin. Bone Marrow Transplant. 2005;35(5):515\u20139.","journal-title":"Bone Marrow Transplant."},{"issue":"8","key":"1010_CR46","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.bbmt.2012.04.005","volume":"18","author":"PJ Martin","year":"2012","unstructured":"Martin PJ, Rizzo JD, Wingard JR, Ballen K, Curtin PT, Cutler C, et\u00a0al. First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2012;18(8):1150\u201363.","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant."},{"issue":"9674","key":"1010_CR47","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","volume":"373","author":"JLM Ferrara","year":"2009","unstructured":"Ferrara JLM, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet Lond Engl. 2009;373(9674):1550\u201361.","journal-title":"Lancet Lond Engl."},{"issue":"12","key":"1010_CR48","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1182\/blood.2023020073","volume":"142","author":"O Jamy","year":"2023","unstructured":"Jamy O, Zeiser R, Chen YB. Novel developments in the prophylaxis and treatment of acute GVHD. Blood. 2023;142(12):1037\u201346.","journal-title":"Blood."},{"issue":"3","key":"1010_CR49","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1097\/00007890-199309000-00016","volume":"56","author":"IM Hings","year":"1993","unstructured":"Hings IM, Filipovich AH, Miller WJ, Blazar BL, McGlave PB, Ramsay NK, et\u00a0al. Prednisone therapy for acute graft-versus-host disease: short- versus long-term treatment. A prospective randomized trial. Transplantation. 1993;56(3):577\u201380.","journal-title":"Transplantation."},{"issue":"6","key":"1010_CR50","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3324\/haematol.2014.118471","volume":"100","author":"M Mielcarek","year":"2015","unstructured":"Mielcarek M, Furlong T, Storer BE, Green ML, McDonald GB, Carpenter PA, et\u00a0al. Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial. Haematologica. 2015;100(6):842\u20138.","journal-title":"Haematologica."},{"issue":"19","key":"1010_CR51","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1056\/NEJMoa1917635","volume":"382","author":"R Zeiser","year":"2020","unstructured":"Zeiser R, von Bubnoff N, Butler J, Mohty M, Niederwieser D, Or R, et\u00a0al. Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease. N Engl J Med. 2020;382(19):1800\u201310.","journal-title":"N Engl J Med."},{"issue":"7","key":"1010_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0271979","volume":"17","author":"M Zhang","year":"2022","unstructured":"Zhang M, Zhao P, Zhang Y, Wang J. Efficacy and safety of ruxolitinib for steroid-refractory graft-versus-host disease: systematic review and meta-analysis of randomised and non-randomised studies. PLOS One. 2022;17(7):e0271979.","journal-title":"PLOS One"},{"issue":"5","key":"1010_CR53","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.bbmt.2020.01.018","volume":"26","author":"J Kurtzberg","year":"2020","unstructured":"Kurtzberg J, Abdel-Azim H, Carpenter P, Chaudhury S, Horn B, Mahadeo K, et\u00a0al. A phase 3, single-arm, prospective study of remestemcel-L, ex vivo culture-expanded adult human mesenchymal stromal cells for the treatment of pediatric patients who failed to respond to steroid treatment for acute graft-versus-host disease. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2020;26(5):845\u201354.","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant."},{"issue":"2, Supplement","key":"1010_CR54","doi-asserted-by":"publisher","first-page":"S288","DOI":"10.1016\/j.jtct.2025.01.439","volume":"31","author":"J Kurtzberg","year":"2025","unstructured":"Kurtzberg J, Burke E, Hayes J, Rose DE, Itescu S. Ryoncil (remestemcel-L) for third-line treatment of SR-aGVHD in adolescents and adults. Transplant Cell Ther. 2025;31(2, Supplement):S288-9.","journal-title":"Transplant Cell Ther."},{"issue":"20","key":"1010_CR55","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1182\/blood.2023022565","volume":"144","author":"F Locatelli","year":"2024","unstructured":"Locatelli F, Kang HJ, Bruno B, Gandemer V, Rialland F, Faraci M, et\u00a0al. Ruxolitinib for pediatric patients with treatment-na\u00efve and steroid-refractory acute graft-versus-host disease: the REACH4 study. Blood. 2024;144(20):2095\u2013106.","journal-title":"Blood."},{"issue":"2","key":"1010_CR56","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.bbmt.2019.10.031","volume":"26","author":"FF Tang","year":"2020","unstructured":"Tang FF, Cheng YF, Xu LP, Zhang XH, Yan CH, Han W, et\u00a0al. Basiliximab as treatment for steroid-refractory acute graft-versus-host disease in pediatric patients after haploidentical hematopoietic stem cell transplantation. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2020;26(2):351\u20137.","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant."},{"issue":"26","key":"1010_CR57","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1056\/NEJMra1703472","volume":"377","author":"R Zeiser","year":"2017","unstructured":"Zeiser R, Blazar BR. Pathophysiology of chronic graft-versus-host disease and therapeutic targets. N Engl J Med. 2017;377(26):2565\u201379.","journal-title":"N Engl J Med."},{"issue":"4","key":"1010_CR58","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3324\/haematol.2016.150250","volume":"102","author":"Y Inamoto","year":"2017","unstructured":"Inamoto Y, Lee SJ. Late effects of blood and marrow transplantation. Haematologica. 2017;102(4):614\u201325.","journal-title":"Haematologica."},{"issue":"10","key":"1010_CR59","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/j.bbmt.2016.06.020","volume":"22","author":"M Grube","year":"2016","unstructured":"Grube M, Holler E, Weber D, Holler B, Herr W, Wolff D. Risk factors and outcome of chronic graft-versus-host disease after allogeneic stem cell transplantation-results from a single-center observational study. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2016;22(10):1781\u201391.","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant."},{"issue":"11","key":"1010_CR60","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1200\/JCO.2009.26.7757","volume":"28","author":"JM Goldman","year":"2010","unstructured":"Goldman JM, Majhail NS, Klein JP, Wang Z, Sobocinski KA, Arora M, et\u00a0al. Relapse and late mortality in 5-year survivors of myeloablative allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in first chronic phase. J Clin Oncol. 2010;28(11):1888\u201395.","journal-title":"J Clin Oncol."},{"issue":"10","key":"1010_CR61","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1182\/blood-2007-03-082933","volume":"110","author":"S Bhatia","year":"2007","unstructured":"Bhatia S, Francisco L, Carter A, Sun CL, Baker KS, Gurney JG, et\u00a0al. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor study. Blood. 2007;110(10):3784\u201392.","journal-title":"Blood."},{"issue":"1","key":"1010_CR62","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1056\/NEJM199907013410103","volume":"341","author":"G Soci\u00e9","year":"1999","unstructured":"Soci\u00e9 G, Stone JV, Wingard JR, Weisdorf D, Henslee-Downey PJ, Bredeson C, et\u00a0al. Long-term survival and late deaths after allogeneic bone marrow transplantation. N Engl J Med. 1999;341(1):14\u201321.","journal-title":"N Engl J Med."},{"issue":"6","key":"1010_CR63","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1200\/JCO.2009.25.6693","volume":"28","author":"PJ Martin","year":"2010","unstructured":"Martin PJ, Counts GW, Appelbaum FR, Lee SJ, Sanders JE, Deeg HJ, et\u00a0al. Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation. J Clin Oncol. 2010;28(6):1011\u20136.","journal-title":"J Clin Oncol."},{"issue":"16","key":"1010_CR64","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1200\/JCO.2010.33.7212","volume":"29","author":"JR Wingard","year":"2011","unstructured":"Wingard JR, Majhail NS, Brazauskas R, Wang Z, Sobocinski KA, Jacobsohn D, et\u00a0al. Long-term survival and late deaths after allogeneic hematopoietic cell transplantation. J Clin Oncol Off J Am Soc Clin Oncol. 2011;29(16):2230\u20139.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol."},{"issue":"6","key":"1010_CR65","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1097\/TP.0000000000005298","volume":"109","author":"JR Boiko","year":"2025","unstructured":"Boiko JR, Hill GR. Chronic graft-versus-host disease: immune insights, therapeutic advances, and parallels for solid organ transplantation. Transplantation. 2025;109(6):955.","journal-title":"Transplantation."},{"issue":"2","key":"1010_CR66","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.bbmt.2016.09.023","volume":"23","author":"KR Cooke","year":"2017","unstructured":"Cooke KR, Luznik L, Sarantopoulos S, Hakim FT, Jagasia M, Fowler DH, et\u00a0al. The biology of chronic graft-versus-host disease: a task force report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2017;23(2):211\u201334.","journal-title":"Biol Blood Marrow Transplant."},{"issue":"1","key":"1010_CR67","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s40257-017-0306-9","volume":"19","author":"K Strong Rodrigues","year":"2018","unstructured":"Strong Rodrigues K, Oliveira-Ribeiro C, de Abreu Fiuza Gomes S, Knobler R. Cutaneous graft-versus-host disease: diagnosis and treatment. Am J Clin Dermatol. 2018;19(1):33\u201350.","journal-title":"Am J Clin Dermatol."},{"issue":"25","key":"1010_CR68","doi-asserted-by":"publisher","first-page":"5098","DOI":"10.1182\/blood-2012-10-464198","volume":"121","author":"Y Inamoto","year":"2013","unstructured":"Inamoto Y, Storer BE, Petersdorf EW, Nelson JL, Lee SJ, Carpenter PA, et\u00a0al. Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease. Blood. 2013;121(25):5098\u2013103.","journal-title":"Blood."},{"issue":"15","key":"1010_CR69","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1182\/blood-2011-04-350249","volume":"118","author":"KJ Martires","year":"2011","unstructured":"Martires KJ, Baird K, Steinberg SM, Grkovic L, Joe GO, Williams KM, et\u00a0al. Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease. Blood. 2011;118(15):4250\u20137.","journal-title":"Blood."},{"issue":"8","key":"1010_CR70","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jtct.2021.03.029","volume":"27","author":"J Pidala","year":"2021","unstructured":"Pidala J, Kitko C, Lee SJ, Carpenter P, Cuvelier GDE, Holtan S, et\u00a0al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group report. Transplant Cell Ther. 2021;27(8):632\u201341.","journal-title":"Transplant Cell Ther."},{"issue":"3","key":"1010_CR71","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1056\/NEJMoa2503189","volume":"393","author":"DJ Curtis","year":"2025","unstructured":"Curtis DJ, Patil SS, Reynolds J, Purtill D, Lewis C, Ritchie DS, et\u00a0al. Graft-versus-host disease prophylaxis with cyclophosphamide and cyclosporin. N Engl J Med. 2025;393(3):243\u201354.","journal-title":"N Engl J Med."},{"issue":"4","key":"1010_CR72","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1200\/JCO.21.02293","volume":"40","author":"L Luznik","year":"2022","unstructured":"Luznik L, Pasquini MC, Logan B, Soiffer RJ, Wu J, Devine SM, et\u00a0al. Randomized Phase III BMT CTN trial of calcineurin inhibitor-free chronic graft-versus-host disease interventions in myeloablative hematopoietic cell transplantation for hematologic malignancies. J Clin Oncol. 2022;40(4):356\u201368.","journal-title":"J Clin Oncol."},{"issue":"4","key":"1010_CR73","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1111\/bjd.13894","volume":"173","author":"I Palacios-Alvarez","year":"2015","unstructured":"Palacios-Alvarez I, Santos-Briz A, Jorge-Finnigan C, Ca\u00f1ueto J, Fernandez-L\u00f3pez E, Roman-Curto C. Chronic cutaneous lichenoid graft-versus-host disease at the area of herpes zoster infection and at a vaccination site. Br J Dermatol. 2015;173(4):1050\u20133.","journal-title":"Br J Dermatol."},{"issue":"4","key":"1010_CR74","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/BF02983564","volume":"78","author":"N Kawano","year":"2003","unstructured":"Kawano N, Gondo H, Kamimura T, Aoki K, Iino T, Ishikawa F, et\u00a0al. Chronic graft-versus-host disease following varicella-zoster virus infection in allogeneic stem cell transplant recipients. Int J Hematol. 2003;78(4):370\u20133.","journal-title":"Int J Hematol."},{"issue":"7","key":"1010_CR75","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1046\/j.1365-4362.2003.01723_2.x","volume":"42","author":"H Anli","year":"2003","unstructured":"Anli H, Anadolu R, Arat M, Ekmekci P, Birol A, Erdem C, et\u00a0al. Dermatomal lichenoid graft-versus-host disease within herpes zoster scars. Int J Dermatol. 2003;42(7):562\u20134.","journal-title":"Int J Dermatol."},{"issue":"5\u20136","key":"1010_CR76","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/phpp.12273","volume":"32","author":"JM Hardy","year":"2016","unstructured":"Hardy JM, Marguery MC, Huynh A, Borel C, Apoil PA, Lamant L, et\u00a0al. Photo-induced graft-versus-host disease. Photodermatol Photoimmunol Photomed. 2016;32(5\u20136):291\u20135.","journal-title":"Photodermatol Photoimmunol Photomed."},{"issue":"4","key":"1010_CR77","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1177\/0022034515570942","volume":"94","author":"CW Bassim","year":"2015","unstructured":"Bassim CW, Fassil H, Mays JW, Edwards D, Baird K, Steinberg SM, et\u00a0al. Oral disease profiles in chronic graft versus host disease. J Dent Res. 2015;94(4):547\u201354.","journal-title":"J Dent Res."},{"issue":"2","key":"1010_CR78","doi-asserted-by":"publisher","first-page":"228.e1","DOI":"10.1016\/j.jtct.2023.10.025","volume":"30","author":"K Ganesan","year":"2024","unstructured":"Ganesan K, Duraisamy S, Meena SK, Yenigalla N, Swaminathan VV, Uppuluri R, et\u00a0al. Genital graft-versus-host disease in children: an underdiagnosed and undertreated entity. Transplant Cell Ther. 2024;30(2):228.e1-228.e5.","journal-title":"Transplant Cell Ther."},{"issue":"3","key":"1010_CR79","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.sjopt.2013.06.007","volume":"27","author":"A Nassar","year":"2013","unstructured":"Nassar A, Tabbara KF, Aljurf M. Ocular manifestations of graft-versus-host disease. Saudi J Ophthalmol. 2013;27(3):215\u201322.","journal-title":"Saudi J Ophthalmol."},{"issue":"11","key":"1010_CR80","doi-asserted-by":"publisher","first-page":"8415","DOI":"10.3390\/curroncol29110663","volume":"29","author":"AD Kvinge","year":"2022","unstructured":"Kvinge AD, Kvammen T, Miletic H, Bindoff LA, Reikvam H. Musculoskeletal chronic graft versus host disease\u2014A rare complication to allogeneic hematopoietic stem cell transplant: a case-based report and review of the literature. Curr Oncol. 2022;29(11):8415\u201330.","journal-title":"Curr Oncol."},{"issue":"2","key":"1010_CR81","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1182\/blood-2002-01-0011","volume":"100","author":"MED Flowers","year":"2002","unstructured":"Flowers MED, Parker PM, Johnston LJ, Matos AVB, Storer B, Bensinger WI, et\u00a0al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood. 2002;100(2):415\u20139.","journal-title":"Blood."},{"issue":"10","key":"1010_CR82","first-page":"1163","volume":"88","author":"S Spinelli","year":"2003","unstructured":"Spinelli S, Chiodi S, Costantini S, Van Lint MT, Raiola AM, Ravera G, et\u00a0al. Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation. Haematologica. 2003;88(10):1163\u20138.","journal-title":"Haematologica."},{"issue":"8","key":"1010_CR83","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/sj.bmt.1705487","volume":"38","author":"D Zantomio","year":"2006","unstructured":"Zantomio D, Grigg AP, MacGregor L, Panek-Hudson Y, Szer J, Ayton R. Female genital tract graft-versus-host disease: incidence, risk factors and recommendations for management. Bone Marrow Transplant. 2006;38(8):567\u201372.","journal-title":"Bone Marrow Transplant."},{"issue":"7","key":"1010_CR84","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jtct.2021.03.033","volume":"27","author":"CL Kitko","year":"2021","unstructured":"Kitko CL, Pidala J, Schoemans HM, Lawitschka A, Flowers ME, Cowen EW, et\u00a0al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group report. Transplant Cell Ther. 2021;27(7):545\u201357.","journal-title":"Transplant Cell Ther."},{"issue":"5","key":"1010_CR85","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1097\/01.AOG.0000285998.75450.86","volume":"110","author":"P Stratton","year":"2007","unstructured":"Stratton P, Turner ML, Childs R, Barrett J, Bishop M, Wayne AS, et\u00a0al. Vulvovaginal chronic graft-versus-host disease with allogeneic hematopoietic stem cell transplantation. Obstet Gynecol. 2007;110(5):1041\u20139.","journal-title":"Obstet Gynecol."},{"issue":"4","key":"1010_CR86","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1001\/jamadermatol.2022.6624","volume":"159","author":"E Baumrin","year":"2023","unstructured":"Baumrin E, Baker LX, Byrne M, Martin PJ, Flowers ME, Onstad L, et\u00a0al. Prognostic value of cutaneous disease severity estimates on survival outcomes in patients with chronic graft-vs-host disease. JAMA Dermatol. 2023;159(4):393\u2013402.","journal-title":"JAMA Dermatol."},{"issue":"5","key":"1010_CR87","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1001\/archderm.134.5.602","volume":"134","author":"S Aractingi","year":"1998","unstructured":"Aractingi S, Chosidow O. Cutaneous graft-versus-host disease. Arch Dermatol. 1998;134(5):602\u201312.","journal-title":"Arch Dermatol."},{"issue":"5, Part 2","key":"1010_CR88","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/0190-9622(93)70126-E","volume":"28","author":"B Beers","year":"1993","unstructured":"Beers B, Kalish RS, Kaye VN, Dahl MV. Unilateral linear lichenoid eruption after bone marrow transplantation: an unmasking of tolerance to an abnormal keratinocyte clone? J Am Acad Dermatol. 1993;28(5, Part 2):888\u201392.","journal-title":"J Am Acad Dermatol."},{"issue":"11","key":"1010_CR89","doi-asserted-by":"publisher","first-page":"951.e1","DOI":"10.1016\/j.jtct.2021.07.022","volume":"27","author":"G Fatobene","year":"2021","unstructured":"Fatobene G, Shinohara MM, Onstad LE, Silgard ET, Martin PJ, Milano F, et\u00a0al. Frequent eczematous dermatitis in unrelated cord blood hematopoietic cell transplant recipients compared with other donor types. Transplant Cell Ther. 2021;27(11):951.e1-951.e6.","journal-title":"Transplant Cell Ther."},{"issue":"10","key":"1010_CR90","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/cup.13000","volume":"44","author":"PB Milam","year":"2017","unstructured":"Milam PB, Vasu SV, Gru AA, Kaffenberger BH. Psoriasiform graft-versus-host disease distributed along Blaschko\u2019s lines. J Cutan Pathol. 2017;44(10):882\u20136.","journal-title":"J Cutan Pathol."},{"issue":"4","key":"1010_CR91","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/ajd.14144","volume":"64","author":"Y Gu","year":"2023","unstructured":"Gu Y, Sun J, Zhang J. Psoriasiform graft-versus-host disease responded to secukinumab: a case report. Australas J Dermatol. 2023;64(4):534\u20136.","journal-title":"Australas J Dermatol."},{"issue":"5","key":"1010_CR92","doi-asserted-by":"publisher","first-page":"e339","DOI":"10.1111\/1346-8138.17598","volume":"52","author":"S Nakazato","year":"2025","unstructured":"Nakazato S, Takashima S, Matsukawa T, Anan T, Ujiie H, Matsuno Y. Psoriasiform graft-versus-host disease with distal sweat duct involvement as the diagnostic histopathological feature. J Dermatol. 2025;52(5):e339-40.","journal-title":"J Dermatol."},{"issue":"7","key":"1010_CR93","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/DAD.0000000000001078","volume":"40","author":"S Vernali","year":"2018","unstructured":"Vernali S, Vertes George E, Gonzalez Santiago T, Motaparthi K. Psoriasiform graft-versus-host disease: report and brief review of the literature. Am J Dermatopathol. 2018;40(7):511\u20134.","journal-title":"Am J Dermatopathol."},{"issue":"1","key":"1010_CR94","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/cup.14444","volume":"51","author":"CL Okorie","year":"2024","unstructured":"Okorie CL, Salem I, Scripture AJ, Simmons BJ, Momtahen S, Yan S. Unusual presentations of chronic graft versus host disease. J Cutan Pathol. 2024;51(1):15\u20139.","journal-title":"J Cutan Pathol."},{"issue":"4","key":"1010_CR95","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.jaad.2014.12.022","volume":"72","author":"CM Cornejo","year":"2015","unstructured":"Cornejo CM, Kim EJ, Rosenbach M, Micheletti RG. Atypical manifestations of graft-versus-host disease. J Am Acad Dermatol. 2015;72(4):690\u20135.","journal-title":"J Am Acad Dermatol."},{"issue":"1","key":"1010_CR96","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1182\/blood-2015-08-662874","volume":"127","author":"J Palmer","year":"2016","unstructured":"Palmer J, Chai X, Pidala J, Inamoto Y, Martin PJ, Storer B, et\u00a0al. Predictors of survival, nonrelapse mortality, and failure-free survival in patients treated for chronic graft-versus-host disease. Blood. 2016;127(1):160\u20136.","journal-title":"Blood."},{"issue":"5","key":"1010_CR97","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.jaad.2019.03.031","volume":"81","author":"DH Marks","year":"2019","unstructured":"Marks DH, Naftulin JS, Penzi LR, Manatis-Lornell A, Yasuda MR, Chapman CM, et\u00a0al. Histologic and clinical cross-sectional study of chronic hair loss in patients with cutaneous chronic graft-versus-host disease. J Am Acad Dermatol. 2019;81(5):1134\u201341.","journal-title":"J Am Acad Dermatol."},{"issue":"3","key":"1010_CR98","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/j.1365-4632.2004.01629.x","volume":"43","author":"H Sanli","year":"2004","unstructured":"Sanli H, Arat M, Oskay T, G\u00fcrman G. Evaluation of nail involvement in patients with chronic cutaneous graft versus host disease: a single-center study from Turkey. Int J Dermatol. 2004;43(3):176\u201380.","journal-title":"Int J Dermatol."},{"issue":"13","key":"1010_CR99","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1182\/blood-2012-04-424135","volume":"120","author":"DA Jacobsohn","year":"2012","unstructured":"Jacobsohn DA, Kurland BF, Pidala J, Inamoto Y, Chai X, Palmer JM, et\u00a0al. Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium. Blood. 2012;120(13):2545\u201352.","journal-title":"Blood."},{"issue":"2","key":"1010_CR100","first-page":"91","volume":"27","author":"H \u015eanl\u0131","year":"2010","unstructured":"\u015eanl\u0131 H, Akay BN, Soydan E, Ko\u00e7yi\u011fit P, Arat M, \u0130lhan O. Clinical aspects of sclerodermatous type graft-versus-host disease after allogeneic hematopoietic cell transplantation. Turk J Haematol Off J Turk Soc Haematol. 2010;27(2):91\u20138.","journal-title":"Turk J Haematol Off J Turk Soc Haematol."},{"issue":"4","key":"1010_CR101","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.jaad.2005.06.015","volume":"53","author":"JV Schaffer","year":"2005","unstructured":"Schaffer JV, McNiff JM, Seropian S, Cooper DL, Bolognia JL. Lichen sclerosus and eosinophilic fasciitis as manifestations of chronic graft-versus-host disease: expanding the sclerodermoid spectrum. J Am Acad Dermatol. 2005;53(4):591\u2013601.","journal-title":"J Am Acad Dermatol."},{"issue":"9","key":"1010_CR102","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1001\/archdermatol.2011.226","volume":"147","author":"KJ Martires","year":"2011","unstructured":"Martires KJ, Baird K, Citrin DE, Hakim FT, Pavletic SZ, Cowen EW. Localization of sclerotic-type chronic graft-vs-host disease to sites of skin injury: potential insight into the mechanism of isomorphic and isotopic responses. Arch Dermatol. 2011;147(9):1081\u20136.","journal-title":"Arch Dermatol."},{"issue":"9","key":"1010_CR103","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1001\/archderm.144.9.1229","volume":"144","author":"AR Patel","year":"2008","unstructured":"Patel AR, Pavletic SZ, Turner ML, Cowen EW. The isomorphic response in morphealike chronic graft-vs-host disease. Arch Dermatol. 2008;144(9):1229\u201331.","journal-title":"Arch Dermatol."},{"issue":"7","key":"1010_CR104","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/j.1365-4632.2008.03611.x","volume":"47","author":"EF Kung","year":"2008","unstructured":"Kung EF, Soltani K, Petronic-Rosic V. Clinicopathologic challenge. Sclerodermoid graft-versus-host disease (GVHD) with lichensclerosus-like lesions. Int J Dermatol. 2008;47(7):655\u20137.","journal-title":"Int J Dermatol."},{"key":"1010_CR105","doi-asserted-by":"crossref","unstructured":"Nielson C, Fraga GR, Fischer R, Rajpara A. Pressure-induced isomorphic sclerodermoid graft-versus-host disease from brassiere underwire and tight-fitting watch. Dermatol Online J. 2015;21(11):13030\/qt74d3w4cn.","DOI":"10.5070\/D32111029298"},{"issue":"10","key":"1010_CR106","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1182\/blood-2011-04-314815","volume":"118","author":"PA Carpenter","year":"2011","unstructured":"Carpenter PA. How I conduct a comprehensive chronic graft-versus-host disease assessment. Blood. 2011;118(10):2679\u201387.","journal-title":"Blood."},{"issue":"2020","key":"1010_CR107","first-page":"9250923","volume":"27","author":"J Deen","year":"2020","unstructured":"Deen J, Byrom L, Robertson I. Calcinosis cutis associated with chronic sclerodermoid graft versus host disease: a case and review of the literature. Case Rep Dermatol Med. 2020;27(2020):9250923.","journal-title":"Case Rep Dermatol Med."},{"issue":"3","key":"1010_CR108","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/s41409-018-0309-z","volume":"54","author":"JS Naftulin","year":"2019","unstructured":"Naftulin JS, Penzi LR, Manatis-Lornell A, Yasuda MR, Porter ML, Saavedra A, et\u00a0al. Longstanding alopecia and nail dystrophy are associated with more severe overall chronic graft-versus-host disease in adults. Bone Marrow Transplant. 2019;54(3):469\u201372.","journal-title":"Bone Marrow Transplant."},{"issue":"11","key":"1010_CR109","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/DAD.0000000000002841","volume":"46","author":"SM Alvarado","year":"2024","unstructured":"Alvarado SM, Cohen OG, Lattanzio K, Haun P, Gelfand JM, Loren AW, et\u00a0al. Histopathologic analysis of chronic cutaneous graft-versus-host disease. Am J Dermatopathol. 2024;46(11):755\u201360.","journal-title":"Am J Dermatopathol."},{"issue":"4","key":"1010_CR110","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/art.38293","volume":"66","author":"Y Inamoto","year":"2014","unstructured":"Inamoto Y, Pidala J, Chai X, Kurland BF, Weisdorf D, Flowers MED, et\u00a0al. Assessment of joint and fascia manifestations in chronic graft-versus-host disease. Arthritis Rheumatol. 2014;66(4):1044\u201352.","journal-title":"Arthritis Rheumatol."},{"issue":"8","key":"1010_CR111","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/archdermatol.2009.78","volume":"145","author":"J Clark","year":"2009","unstructured":"Clark J, Yao L, Pavletic SZ, Krumlauf M, Mitchell S, Turner ML, et\u00a0al. Magnetic resonance imaging in sclerotic-type chronic graft-vs-host disease. Arch Dermatol. 2009;145(8):918\u201322.","journal-title":"Arch Dermatol."},{"issue":"9","key":"1010_CR112","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.jtct.2021.05.030","volume":"27","author":"H Shakshouk","year":"2021","unstructured":"Shakshouk H, Tkaczyk ER, Cowen EW, el-Azhary RA, Hashmi SK, Kenderian SJ, et\u00a0al. Methods to assess disease activity and severity in cutaneous chronic graft-versus-host disease: a critical literature review. Transplant Cell Ther. 2021;27(9):738\u201346.","journal-title":"Transplant Cell Ther."},{"issue":"2","key":"1010_CR113","first-page":"S283","volume":"31","author":"N Farhadfar","year":"2025","unstructured":"Farhadfar N, Jurdi NE, Ghosh S, Baker K, Bat-Erdene M, Desatnik G, et\u00a0al. Reproducibility and reliability of Myoton to quantify sclerotic chronic graft-versus-host disease. Transplant Cell Ther Off Publ Am Soc Transplant Cell Ther. 2025;31(2):S283-4.","journal-title":"Transplant Cell Ther Off Publ Am Soc Transplant Cell Ther."},{"issue":"134","key":"1010_CR114","doi-asserted-by":"publisher","first-page":"4515","DOI":"10.1182\/blood-2019-129125","volume":"13","author":"F Chen","year":"2019","unstructured":"Chen F, Wang L, Vain A, Ssempijja Y, Dellalana L, Zhang K, et\u00a0al. Interobserver reproducibility of the Myoton and durometer devices to measure skin stiffness and hardness in chronic cutaneous graft-versus-host disease patients. Blood. 2019;13(134):4515.","journal-title":"Blood."},{"issue":"2","key":"1010_CR115","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.2340\/00015555-3747","volume":"101","author":"P Giavedoni","year":"2021","unstructured":"Giavedoni P, Mart\u00ednez C, Podlipnik S, Su\u00e1rez-Lleid\u00f3 M, Mart\u00ed-Mart\u00ed I, Morgado-Carrasco D, et\u00a0al. Assessment of sclerodermoid chronic graft-versus-host disease with colour Doppler ultrasound. Acta Derm Venereol. 2021;101(2):1042.","journal-title":"Acta Derm Venereol."},{"issue":"9","key":"1010_CR116","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1007\/s00403-023-02626-1","volume":"315","author":"S Ghosh","year":"2023","unstructured":"Ghosh S, Baker L, Chen F, Khera Z, Vain A, Zhang K, et\u00a0al. Interrater reproducibility of the Myoton and durometer devices to quantify sclerotic chronic graft-versus-host-disease. Arch Dermatol Res. 2023;315(9):2545\u201354.","journal-title":"Arch Dermatol Res."},{"issue":"11","key":"1010_CR117","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1016\/j.ultrasmedbio.2015.06.007","volume":"41","author":"SY Lee","year":"2015","unstructured":"Lee SY, Cardones A, Doherty J, Nightingale K, Palmeri M. Preliminary results on the feasibility of using ARFI\/SWEI to assess cutaneous sclerotic diseases. Ultrasound Med Biol. 2015;41(11):2806\u201319.","journal-title":"Ultrasound Med Biol."},{"issue":"4","key":"1010_CR118","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/s41409-020-01158-w","volume":"56","author":"LX Baker","year":"2021","unstructured":"Baker LX, Chen F, Ssempijja Y, Byrne M, Kim TK, Vain A, et\u00a0al. Longitudinal tracking of skin dynamic stiffness to quantify evolution of sclerosis in chronic graft-versus-host disease. Bone Marrow Transplant. 2021;56(4):989\u201391.","journal-title":"Bone Marrow Transplant."},{"issue":"156","key":"1010_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijthermalsci.2020.106350","volume":"1","author":"B Marchetti","year":"2020","unstructured":"Marchetti B, Leporini M, Corvaro F, Olivieri A, Ighani M, Chiarucci M. Application of infrared thermography to determine the correlation between skin temperature and onset of graft versus host disease in patients after bone marrow transplantation: a preliminary study. Int J Therm Sci. 2020;1(156):106350.","journal-title":"Int J Therm Sci."},{"issue":"3","key":"1010_CR120","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/srt.12646","volume":"25","author":"LE Dellalana","year":"2019","unstructured":"Dellalana LE, Chen F, Vain A, Gandelman JS, P\u00f5ldemaa M, Chen H, et\u00a0al. Reproducibility of the durometer and Myoton devices for skin stiffness measurement in healthy subjects. Skin Res Technol. 2019;25(3):289\u201393.","journal-title":"Skin Res Technol."},{"issue":"26","key":"1010_CR121","first-page":"00021","volume":"S2666\u20136367","author":"A Markova","year":"2026","unstructured":"Markova A, Lee SJ, Modi B, Baumrin E, Rosenstein RK, Tkaczyk ER, et\u00a0al. Towards better response assessment of cutaneous chronic graft-versus-host disease: a report from the National Institutes of Health Consensus Project Task Force. Transplant Cell Ther. 2026;S2666\u20136367(26):00021\u20137.","journal-title":"Transplant Cell Ther."},{"issue":"14","key":"1010_CR122","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.1182\/bloodadvances.2022007715","volume":"7","author":"GDE Cuvelier","year":"2022","unstructured":"Cuvelier GDE, Ng B, Abdossamadi S, Nemecek ER, Melton A, Kitko CL, et\u00a0al. A diagnostic classifier for pediatric chronic graft-versus-host disease: results of the ABLE\/PBMTC 1202 study. Blood Adv. 2022;7(14):3612\u201323.","journal-title":"Blood Adv."},{"key":"1010_CR123","doi-asserted-by":"crossref","unstructured":"Logan BR, Fu D, Howard A, Fei M, Kou J, Little MR, et\u00a0al. Validated graft-specific biomarkers identify patients at risk for chronic graft-versus-host disease and death. J Clin Invest. 133(15):e168575.","DOI":"10.1172\/JCI168575"},{"issue":"20","key":"1010_CR124","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.1182\/blood-2012-02-413260","volume":"120","author":"JE Croudace","year":"2012","unstructured":"Croudace JE, Inman CF, Abbotts BE, Nagra S, Nunnick J, Mahendra P, et\u00a0al. Chemokine-mediated tissue recruitment of CXCR3+ CD4+ T cells plays a major role in the pathogenesis of chronic GVHD. Blood. 2012;120(20):4246\u201355.","journal-title":"Blood."},{"issue":"7","key":"1010_CR125","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/DAD.0000000000000357","volume":"37","author":"A Fischer","year":"2015","unstructured":"Fischer A, Jakubowski AA, Lacouture ME, Hollmann TJ, Drucker AM, Maloy M, et\u00a0al. Histopathologic features of cutaneous acute graft-versus-host disease in T-cell-depleted peripheral blood stem cell transplant recipients. Am J Dermatopathol. 2015;37(7):523\u20139.","journal-title":"Am J Dermatopathol."},{"issue":"6","key":"1010_CR126","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.bbmt.2015.02.025","volume":"21","author":"SJ Lee","year":"2015","unstructured":"Lee SJ, Wolff D, Kitko C, Koreth J, Inamoto Y, Jagasia M, et\u00a0al. Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group report. Biol Blood Marrow Transplant. 2015;21(6):984\u201399.","journal-title":"Biol Blood Marrow Transplant."},{"issue":"4","key":"1010_CR127","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1001\/jamadermatol.2023.6277","volume":"160","author":"E Baumrin","year":"2024","unstructured":"Baumrin E, Shin DB, Mitra N, Pidala J, El Jurdi N, Lee SJ, et\u00a0al. Patient-reported outcomes and mortality in cutaneous chronic graft-vs-host disease. JAMA Dermatol. 2024;160(4):393\u2013401.","journal-title":"JAMA Dermatol."},{"issue":"12","key":"1010_CR128","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1182\/blood.2024027334","volume":"145","author":"E Baumrin","year":"2025","unstructured":"Baumrin E, Pidala J, Mitchell SA, Onstad L, Lee SJ. Development of the Lee Symptom Scale-Skin Sclerosis for chronic GVHD-associated sclerosis. Blood. 2025;145(12):1321\u201332.","journal-title":"Blood."},{"issue":"1","key":"1010_CR129","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jaad.2022.12.023","volume":"90","author":"E Baumrin","year":"2024","unstructured":"Baumrin E, Loren AW, Falk SJ, Mays JW, Cowen EW. Chronic graft-versus-host disease. Part II: disease activity grading and therapeutic management. J Am Acad Dermatol. 2024;90(1):19\u201336.","journal-title":"J Am Acad Dermatol."},{"issue":"7","key":"1010_CR130","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.bbmt.2015.03.024","volume":"21","author":"PA Carpenter","year":"2015","unstructured":"Carpenter PA, Kitko CL, Elad S, Flowers MED, Gea-Banacloche JC, Halter JP, et\u00a0al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group report. Biol Blood Marrow Transplant. 2015;21(7):1167\u201387.","journal-title":"Biol Blood Marrow Transplant."},{"issue":"9","key":"1010_CR131","first-page":"665","volume":"16","author":"S Elad","year":"2003","unstructured":"Elad S, Or R, Resnick I, Shapira MY. Topical tacrolimus\u2014A novel treatment alternative for cutaneous chronic graft-versus-host disease. Transpl Int. 2003;16(9):665\u201370.","journal-title":"Transpl Int."},{"issue":"9","key":"1010_CR132","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1001\/archderm.137.9.1202","volume":"137","author":"CJ Choi","year":"2001","unstructured":"Choi CJ, Nghiem P. Tacrolimus ointment in the treatment of chronic cutaneous graft-vs-host disease: a case series of 18 patients. Arch Dermatol. 2001;137(9):1202\u20136.","journal-title":"Arch Dermatol."},{"issue":"6","key":"1010_CR133","first-page":"946","volume":"50","author":"M Ziemer","year":"2004","unstructured":"Ziemer M, Gruhn B, Thiele JJ, Elsner P. Treatment of extensive chronic cutaneous graft-versus-host disease in an infant with topical pimecrolimus. J Am Acad Dermatol. 2004;50(6):946\u20138.","journal-title":"J Am Acad Dermatol."},{"issue":"1","key":"1010_CR134","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/sj.bmt.1704998","volume":"36","author":"T Schmook","year":"2005","unstructured":"Schmook T, Kraft J, Benninghoff B, Nindl I, Roewert J, Ulrich C, et\u00a0al. Treatment of cutaneous chronic graft-versus-host disease with topical pimecrolimus. Bone Marrow Transplant. 2005;36(1):87\u20138.","journal-title":"Bone Marrow Transplant."},{"issue":"Supplement 1","key":"1010_CR135","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1182\/blood-2023-182198","volume":"142","author":"A Markova","year":"2023","unstructured":"Markova A, Papadopoulos EB, Dusza S, Ostoji\u0107 J, Ai R, Maier T, et\u00a0al. Topical ruxolitinib for chronic cutaneous GvHD: promising results of a phase 2 clinical trial. Blood. 2023;142(Supplement 1):777.","journal-title":"Blood."},{"key":"1010_CR136","doi-asserted-by":"crossref","unstructured":"Cooper, Herd, Priestley, A. Hunter. A comparison of bathwater and oral delivery of 8\u2010methoxypsoralen in PUVA therapy for plaque psoriasis. Clin Exp Dermatol. 2000;25(2):111\u20134.","DOI":"10.1046\/j.1365-2230.2000.00589.x"},{"issue":"6","key":"1010_CR137","first-page":"1061","volume":"17","author":"GB Vogelsang","year":"1996","unstructured":"Vogelsang GB, Wolff D, Altomonte V, Farmer E, Morison WL, Corio R, et\u00a0al. Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA). Bone Marrow Transplant. 1996;17(6):1061\u20137.","journal-title":"Bone Marrow Transplant."},{"issue":"1 Pt 1","key":"1010_CR138","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/S0190-9622(85)70005-9","volume":"12","author":"SR Hymes","year":"1985","unstructured":"Hymes SR, Morison WL, Farmer ER, Walters LL, Tutschka PJ, Santos GW. Methoxsalen and ultraviolet A radiation in treatment of chronic cutaneous graft-versus-host reaction. J Am Acad Dermatol. 1985;12(1 Pt 1):30\u20137.","journal-title":"J Am Acad Dermatol."},{"issue":"1, Part 1","key":"1010_CR139","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0190-9622(00)90023-9","volume":"42","author":"M Grundmann-Kollmann","year":"2000","unstructured":"Grundmann-Kollmann M, Behrens S, Gruss C, Gottl\u00f6ber P, Peter RU, Kerscher M. Chronic sclerodermic graft-versus-host disease refractory to immunosuppressive treatment responds to UVA1 phototherapy. J Am Acad Dermatol. 2000;42(1, Part 1):134\u20136.","journal-title":"J Am Acad Dermatol."},{"issue":"8","key":"1010_CR140","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1182\/blood.2024026633","volume":"145","author":"SJ Lee","year":"2025","unstructured":"Lee SJ, Zeiser R. FDA-approved therapies for chronic GVHD. Blood. 2025;145(8):795\u2013800.","journal-title":"Blood."},{"issue":"11","key":"1010_CR141","doi-asserted-by":"publisher","first-page":"771.e1","DOI":"10.1016\/j.jtct.2022.08.021","volume":"28","author":"PA Carpenter","year":"2022","unstructured":"Carpenter PA, Kang HJ, Yoo KH, Zecca M, Cho B, Lucchini G, et\u00a0al. Ibrutinib treatment of pediatric chronic graft-versus-host disease: primary results from the phase 1\/2 iMAGINE study. Transplant Cell Ther. 2022;28(11):771.e1-771.e10.","journal-title":"Transplant Cell Ther."},{"issue":"21","key":"1010_CR142","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1182\/blood-2017-07-793786","volume":"130","author":"D Miklos","year":"2017","unstructured":"Miklos D, Cutler CS, Arora M, Waller EK, Jagasia M, Pusic I, et\u00a0al. Ibrutinib for chronic graft-versus-host disease after failure of prior therapy. Blood. 2017;130(21):2243\u201350.","journal-title":"Blood."},{"issue":"3","key":"1010_CR143","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1056\/NEJMoa2033122","volume":"385","author":"R Zeiser","year":"2021","unstructured":"Zeiser R, Polverelli N, Ram R, Hashmi SK, Chakraverty R, Middeke JM, et\u00a0al. Ruxolitinib for glucocorticoid-refractory chronic graft-versus-host disease. N Engl J Med. 2021;385(3):228\u201338.","journal-title":"N Engl J Med."},{"issue":"33","key":"1010_CR144","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.1200\/JCO.24.00205","volume":"42","author":"VR Bhatt","year":"2024","unstructured":"Bhatt VR, Shostrom VK, Choe HK, Hamilton BK, Gundabolu K, Maness LJ, et\u00a0al. A multicenter phase II trial of ruxolitinib for treatment of corticosteroid refractory sclerotic chronic graft-versus-host disease. J Clin Oncol. 2024;42(33):3977\u201385.","journal-title":"J Clin Oncol."},{"key":"1010_CR145","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.954268\/full","author":"S Fan","year":"2022","unstructured":"Fan S, Huo WX, Yang Y, Shen MZ, Mo XD. Efficacy and safety of ruxolitinib in steroid-refractory graft-versus-host disease: a meta-analysis. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.954268\/full.","journal-title":"Front Immunol."},{"issue":"2","key":"1010_CR146","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jaad.2021.10.004","volume":"86","author":"JQ Lin","year":"2022","unstructured":"Lin JQ, Li SQ, Li S, Kiamanesh EF, Aasi SZ, Kwong BY, et\u00a0al. A 10-year retrospective cohort study of ruxolitinib and association with nonmelanoma skin cancer in patients with polycythemia vera and myelofibrosis. J Am Acad Dermatol. 2022;86(2):339\u201344.","journal-title":"J Am Acad Dermatol."},{"issue":"22","key":"1010_CR147","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1182\/blood.2021012021","volume":"138","author":"C Cutler","year":"2021","unstructured":"Cutler C, Lee SJ, Arai S, Rotta M, Zoghi B, Lazaryan A, et\u00a0al. Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar study. Blood. 2021;138(22):2278\u201389.","journal-title":"Blood."},{"issue":"10","key":"1010_CR148","doi-asserted-by":"publisher","first-page":"700.e1","DOI":"10.1016\/j.jtct.2022.06.020","volume":"28","author":"SJ Lee","year":"2022","unstructured":"Lee SJ, Cutler C, Blazar BR, Tu A, Yang Z, Pavletic SZ. Correlation of patient-reported outcomes with clinical organ responses: data from the belumosudil chronic graft-versus-host disease studies. Transplant Cell Ther. 2022;28(10):700.e1-700.e6.","journal-title":"Transplant Cell Ther."},{"issue":"12","key":"1010_CR149","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1158\/1078-0432.CCR-21-4176","volume":"28","author":"D Przepiorka","year":"2022","unstructured":"Przepiorka D, Le RQ, Ionan A, Li RJ, Wang YH, Gudi R, et\u00a0al. FDA approval summary: belumosudil for adult and pediatric patients 12 years and older with chronic GvHD after two or more prior lines of systemic therapy. Clin Cancer Res. 2022;28(12):2488\u201392.","journal-title":"Clin Cancer Res."},{"key":"1010_CR150","unstructured":"Fred Hutchinson Cancer Center. Randomized phase ii study of belumosudil vs. placebo for preemptive treatment of chronic graft versus host disease. ClinicalTrials.gov; 2025. Report No.: NCT05996627. Available from: https:\/\/ClinicalTrials.gov\/study\/NCT05996627"},{"issue":"11","key":"1010_CR151","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1056\/NEJMoa2401537","volume":"391","author":"D Wolff","year":"2024","unstructured":"Wolff D, Cutler C, Lee SJ, Pusic I, Bittencourt H, White J, et\u00a0al. Axatilimab in recurrent or refractory chronic graft-versus-host disease. N Engl J Med. 2024;391(11):1002\u201314.","journal-title":"N Engl J Med."},{"issue":"3","key":"1010_CR152","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1182\/blood-2009-02-204750","volume":"114","author":"L Magro","year":"2009","unstructured":"Magro L, Mohty M, Catteau B, Coiteux V, Chevallier P, Terriou L, et\u00a0al. Imatinib mesylate as salvage therapy for refractory sclerotic chronic graft-versus-host disease. Blood. 2009;114(3):719\u201322.","journal-title":"Blood."},{"issue":"24","key":"1010_CR153","first-page":"2932","volume":"141","author":"AG Koshy","year":"2023","unstructured":"Koshy AG, Kim HT, Liegel J, Arnason J, Ho VT, Antin JH, et\u00a0al. Phase 2 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease. Blood. 2023;141(24):2932\u201343.","journal-title":"Blood."},{"issue":"9","key":"1010_CR154","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.bbmt.2009.04.003","volume":"15","author":"MA Kharfan-Dabaja","year":"2009","unstructured":"Kharfan-Dabaja MA, Mhaskar AR, Djulbegovic B, Cutler C, Mohty M, Kumar A. Efficacy of rituximab in the setting of steroid-refractory chronic graft-versus-host disease: a systematic review and meta-analysis. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2009;15(9):1005\u201313.","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant."},{"issue":"4","key":"1010_CR155","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/01.TP.0000151630.25127.3A","volume":"79","author":"E Mah\u00e9","year":"2005","unstructured":"Mah\u00e9 E, Morelon E, Lechaton S, Sang KHLQ, Mansouri R, Ducasse MF, et\u00a0al. Cutaneous adverse events in renal transplant recipients receiving sirolimus-based therapy. Transplantation. 2005;79(4):476\u201382.","journal-title":"Transplantation."},{"issue":"9","key":"1010_CR156","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.jtct.2023.07.001","volume":"29","author":"P Asensi Cant\u00f3","year":"2023","unstructured":"Asensi Cant\u00f3 P, Sanz Caballer J, Solves Alca\u00edna P, de la Rubia Comos J, G\u00f3mez SI. Extracorporeal photopheresis in graft-versus-host disease. Transplant Cell Ther. 2023;29(9):556\u201366.","journal-title":"Transplant Cell Ther."},{"issue":"5","key":"1010_CR157","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1177\/2040620713490316","volume":"4","author":"JW Hart","year":"2013","unstructured":"Hart JW, Shiue LH, Shpall EJ, Alousi AM. Extracorporeal photopheresis in the treatment of graft-versus-host disease: evidence and opinion. Ther Adv Hematol. 2013;4(5):320\u201334.","journal-title":"Ther Adv Hematol."},{"issue":"7","key":"1010_CR158","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1182\/blood-2008-03-141481","volume":"112","author":"MED Flowers","year":"2008","unstructured":"Flowers MED, Apperley JF, van Besien K, Elmaagacli A, Grigg A, Reddy V, et\u00a0al. A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease. Blood. 2008;112(7):2667\u201374.","journal-title":"Blood."},{"issue":"4","key":"1010_CR159","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1182\/blood-2002-11-3351","volume":"102","author":"ED Seaton","year":"2003","unstructured":"Seaton ED, Szydlo RM, Kanfer E, Apperley JF, Russell-Jones R. Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response. Blood. 2003;102(4):1217\u201323.","journal-title":"Blood."},{"issue":"8","key":"1010_CR160","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1182\/blood-2005-09-3907","volume":"107","author":"DR Couriel","year":"2006","unstructured":"Couriel DR, Hosing C, Saliba R, Shpall EJ, Anderlini P, Rhodes B, et\u00a0al. Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. Blood. 2006;107(8):3074\u201380.","journal-title":"Blood."},{"issue":"2","key":"1010_CR161","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.transci.2013.02.033","volume":"48","author":"I Bojanic","year":"2013","unstructured":"Bojanic I, Serventi Seiwerth R, Golubic Cepulic B, Mazic S, Lukic M, Raos M, et\u00a0al. Treatment of chronic GVHD with extracorporeal photochemotherapy. Transfus Apher Sci. 2013;48(2):193\u20134.","journal-title":"Transfus Apher Sci."},{"issue":"134","key":"1010_CR162","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2023.107387","volume":"1","author":"SM Linn","year":"2023","unstructured":"Linn SM, Novitzky-Basso I, Patriquin C, Pasic I, Lam W, Law A, et\u00a0al. Single centre retrospective analysis of extracorporeal photopheresis (ECP) therapy in patients heavily pre-treated for chronic graft-versus-host disease (cGvHD) with steroid failure. Leuk Res. 2023;1(134):107387.","journal-title":"Leuk Res."},{"issue":"24","key":"1010_CR163","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1182\/blood.2024026581","volume":"145","author":"YM Zhao","year":"2025","unstructured":"Zhao YM, Luo Y, Shi JM, Wang SQ, Wang CK, Jiang EL, et\u00a0al. A first-in-class JAK\/ROCK inhibitor, rovadicitinib, for glucocorticoid-refractory or -dependent chronic GVHD. Blood. 2025;145(24):2857\u201372.","journal-title":"Blood."},{"issue":"Supplement 1","key":"1010_CR164","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1182\/blood-2023-178956","volume":"142","author":"Z Xu","year":"2023","unstructured":"Xu Z, Pan L, Hong Z, Yin Q, Zuo X, Wen Q, et\u00a0al. First-in-class JAK\/rock inhibitor rovadicitinib in myeloproliferative neoplasms: a single arm, multicenter, open-label, phase I\/Ib study. Blood. 2023;142(Supplement 1):1829.","journal-title":"Blood."},{"issue":"1","key":"1010_CR165","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/10428194.2024.2409876","volume":"66","author":"J Caputo","year":"2025","unstructured":"Caputo J, Peddireddi A, Bhatta S, Huang Y, Bezerra E, Brammer J, et\u00a0al. Combination ruxolitinib and belumosudil is tolerable and induces responses despite treatment failure as monotherapies. Leuk Lymphoma. 2025;66(1):131\u20138.","journal-title":"Leuk Lymphoma."},{"key":"1010_CR166","unstructured":"Incyte Corporation. A phase 3, randomized, double-blind, placebo-controlled study of axatilimab and corticosteroids as initial treatment for chronic graft-versus-host disease. ClinicalTrials.gov; 2025. Report No.: NCT06585774. Available from: https:\/\/ClinicalTrials.gov\/study\/NCT06585774"},{"key":"1010_CR167","unstructured":"Incyte Corporation. A phase 2, open-label, randomized, multicenter study to evaluate the safety and efficacy of axatilimab in combination with ruxolitinib in participants with newly diagnosed chronic graft-versus-host disease. ClinicalTrials.gov; 2025. Report No.: NCT06388564. Available from: https:\/\/ClinicalTrials.gov\/study\/NCT06388564"},{"key":"1010_CR168","unstructured":"Sanofi. A randomized, double-blind, multicenter, phase 3 study to evaluate efficacy and safety of belumosudil in combination with corticosteroids versus placebo in combination with corticosteroids in participants at least 12 years of age with newly diagnosed chronic graft versus host disease (cGVHD). ClinicalTrials.gov; 2025 Jul Report No.: NCT06143891. Available from: https:\/\/ClinicalTrials.gov\/study\/NCT06143891"},{"key":"1010_CR169","unstructured":"Lara C. Pullen P. A study to evaluate the safety and efficacy of axatilimab in combination with ruxolitinib in participants with newly diagnosed chronic graft-versus-host disease (NCT06388564). 2025; Available from: https:\/\/ashpublications.org\/ashclinicalnews\/news\/8515\/A-Study-to-Evaluate-the-Safety-and-Efficacy-of"},{"issue":"4","key":"1010_CR170","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000003018","volume":"47","author":"SL Ishee","year":"2025","unstructured":"Ishee SL, Jenkins MM, Jones MM, Connelly JA. Dupilumab for atopic dermatitis-like chronic graft-versus-host disease in three pediatric hematopoietic cell transplant recipients. J Pediatr Hematol Oncol. 2025;47(4):e128.","journal-title":"J Pediatr Hematol Oncol."},{"issue":"44","key":"1010_CR171","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jdcr.2023.11.003","volume":"1","author":"L Belmesk","year":"2024","unstructured":"Belmesk L, Hatami A, Powell J, Kokta V, Coulombe J. Successful use of dupilumab in recalcitrant pediatric atopic dermatitis-like graft-versus-host disease: a case series. JAAD Case Rep. 2024;1(44):11\u20136.","journal-title":"JAAD Case Rep."},{"issue":"11","key":"1010_CR172","doi-asserted-by":"publisher","first-page":"e1323","DOI":"10.1111\/jdv.19311","volume":"37","author":"R Mital","year":"2023","unstructured":"Mital R, Penza SL, Choe HK, Chung CG, Kaffenberger BH. Dupilumab for refractory sclerotic-type cutaneous graft-versus-host disease. J Eur Acad Dermatol Venereol. 2023;37(11):e1323-4.","journal-title":"J Eur Acad Dermatol Venereol."}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-026-01010-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-026-01010-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-026-01010-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T11:07:40Z","timestamp":1778670460000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-026-01010-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":172,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1010"],"URL":"https:\/\/doi.org\/10.1007\/s40257-026-01010-9","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"IRB Approval Status"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Consent for the publication of recognizable patient photographs or other identifiable material was obtained where applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient Consent on File"}}]}}